Content about Thiophenes

July 16, 2012

UCB has launched a new drug for treating Parkinson's disease and restless legs syndrome, the company said Monday.

June 18, 2012

Greenstone, the generic pharmaceutical subsidiary of Pfizer, has launched olanzapine tablets.

May 24, 2012

A Food and Drug Administration expert panel has recommended against expanding the approval of a Johnson & Johnson drug, the company said.

May 16, 2012

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

April 25, 2012

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

April 24, 2012

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

April 4, 2012

The Food and Drug Administration has approved a patch for treating restless legs syndrome and Parkinson's disease.

March 9, 2012

A regional retail pharmacy chain and a nearby school of pharmacy will collaborate on a study to evaluate the implementation of a pharmacogenetic program in a community pharmacy setting.

February 3, 2012

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

November 7, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for preventing stroke in patients with abnormal heart rhythm, the agency said.

July 21, 2011

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

April 28, 2011

Drug maker Eli Lilly will get at least two more years of patent exclusivity on a drug used to treat depression, anxiety and pain resulting from diabetic neuropathy and fibromyalgia, thanks to a court order issued Wednesday.

April 18, 2011

A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

November 29, 2010

A generic drug maker announced that the Food and Drug Administration has granted tentative approval for its version of a popular antidepressant.

November 14, 2010

An investigational drug made by Johnson & Johnson is more effective in reducing the risk...

November 14, 2010

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

November 4, 2010

The Food and Drug Administration has approved a new usage for a drug used to...

October 6, 2010

The global pharmaceutical market will reach a value of $880 billion next year, according to...

August 19, 2010

A Food and Drug Administration advisory committee has voted to recommend expanding the use of...

March 29, 2010

The U.S. Patent and Trademark Office plans to uphold the patent protection of a blockbuster...

March 11, 2010

A popular drug for preventing blood clots may be less effective when taken by a...

February 7, 2010

Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...

February 2, 2010

A pain drug made by Eli Lilly & Co. “significantly” reduced chronic low back pain...

February 1, 2010

A drug from Boehringer Ingelheim and Pfizer will retain Decision Resources’ status as a gold...

© 2014 Drug Store News. All Rights Reserved.